This work was supported by the American Red Cross, Biomedical Services.
Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms
Article first published online: 27 FEB 2013
© 2013 American Association of Blood Banks
Volume 53, Issue 11, pages 2644–2649, November 2013
How to Cite
Johnson, S. T., Van Tassell, E. R., Tonnetti, L., Cable, R. G., Berardi, V. P. and Leiby, D. A. (2013), Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms. Transfusion, 53: 2644–2649. doi: 10.1111/trf.12125
- Issue published online: 13 NOV 2013
- Article first published online: 27 FEB 2013
- Manuscript Accepted: 13 DEC 2012
- Manuscript Revised: 11 DEC 2012
- Manuscript Received: 7 SEP 2012
- American Red Cross, Biomedical Services
Babesia microti, an intraerythrocytic parasite, has been implicated in transfusion transmission. B. microti seroprevalence in Connecticut (CT) blood donors is approximately 1%; however, it is not known what percentage of donors is parasitemic and poses a risk for transmitting infection. Therefore, we determined the prevalence of demonstrable B. microti DNA in donors from a highly endemic area of CT and compared observed rates with concurrent immunofluorescence assay (IFA) testing results.
Study Design and Methods
Blood samples from consenting donors in southeastern CT were collected from mid-August through early October 2009 and tested by IFA for immunoglobulin G antibodies and real-time polymerase chain reaction (PCR) for B. microti DNA. IFA specificity was determined using blood donor samples collected in northwestern Vermont (VT), an area nonendemic for Babesia.
Of 1002 CT donors, 25 (2.5%) were IFA positive and three (0.3%) were real-time PCR positive. Among the three real-time PCR–positive donors, two were also IFA positive, while one was IFA negative and may represent a window period infection. The two IFA- and real-time PCR–positive donors appeared to subsequently clear infection. The other real-time PCR–positive donor did not provide follow-up samples. Of 1015 VT donors tested by IFA, only one (0.1%) was positive, but may have acquired infection during travel to an endemic area.
We prospectively identified several real-time PCR–positive blood donors, including an IFA-negative real-time PCR–positive donor, in an area highly endemic for B. microti. These results suggest the need to include nucleic acid testing in planned mitigation strategies for B. microti.